Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93741547 | 9374154 | 7 | F | 20160712 | 20130628 | 20160720 | EXP | US-PFIZER INC-2013191019 | PFIZER | 47.00 | YR | F | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93741547 | 9374154 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | V130273 | 21446 | 150 | MG | CAPSULE, HARD | BID | |||||
| 93741547 | 9374154 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||||
| 93741547 | 9374154 | 3 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | |||||||
| 93741547 | 9374154 | 4 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | 50 MG, AS NEEDED EVERY 6 HRS | 0 | 50 | MG | TABLET | ||||||||
| 93741547 | 9374154 | 5 | C | LIDOCAINE. | LIDOCAINE | 1 | APPLY A THIN LAYER TO THE AFFECTED AREA BID-TID | 0 | GEL | ||||||||||
| 93741547 | 9374154 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 50000 IU, WEEKLY | 0 | 50000 | IU | CAPSULE | /wk | |||||||
| 93741547 | 9374154 | 7 | C | BACTROBAN | MUPIROCINMUPIROCIN CALCIUM | 1 | APPLY TO AFFECTED AREA THREE TIMES DAILY | 0 | OINTMENT | TID | |||||||||
| 93741547 | 9374154 | 8 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, 3X/DAY | 0 | 10 | MG | TABLET | TID | ||||||
| 93741547 | 9374154 | 9 | C | HYDROXYZINE HCL | HYDROXYZINE HYDROCHLORIDE | 1 | 25 MG, 4X/DAY | 0 | 25 | MG | TABLET | QID | |||||||
| 93741547 | 9374154 | 10 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | 0.1 MG, 2X/DAY | 0 | .1 | MG | TABLET | BID | |||||||
| 93741547 | 9374154 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 93741547 | 9374154 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 93741547 | 9374154 | 13 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | 20 MG, 4X/DAY | 0 | 20 | MG | TABLET | QID | |||||||
| 93741547 | 9374154 | 14 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 (65 FE) MG TABLET 1 TABLET ONCE A DAY | 0 | 1 | DF | TABLET | QD | |||||||
| 93741547 | 9374154 | 15 | C | LASIX | FUROSEMIDE | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | |||||||
| 93741547 | 9374154 | 16 | C | POTASSIUM CHLORIDE ER | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, 1X/DAY | 0 | 10 | MEQ | PROLONGED-RELEASE TABLET | QD | ||||||
| 93741547 | 9374154 | 17 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | 1 APPLICATION TO AFFECTED AREA TWICE A DAY | 0 | CREAM | BID | |||||||||
| 93741547 | 9374154 | 18 | C | ATROVENT HFA | IPRATROPIUM BROMIDE | 1 | 17MCG AEROSOL SOLUTION INHALE 2 PUFFS FOUR TIMES A DAY | 0 | 34 | UG | INHALATION VAPOUR, SOLUTION | QID | |||||||
| 93741547 | 9374154 | 19 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 4 MG, EVERY 4-6 HRS PRN | 0 | 4 | MG | ORODISPERSIBLE TABLET | ||||||||
| 93741547 | 9374154 | 20 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 MCG/ACT, 2 SPRAYS IN EACH NOSTRIL ONCE A DAY | 0 | 200 | UG | NASAL SPRAY, SUSPENSION | QD | ||||||
| 93741547 | 9374154 | 21 | C | LORATADINE. | LORATADINE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | |||||||
| 93741547 | 9374154 | 22 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | 2 PUFFS EVERY 4-6 HRS PRN | 0 | 2 | DF | |||||||||
| 93741547 | 9374154 | 23 | C | COUMADIN | WARFARIN SODIUM | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93741547 | 9374154 | 1 | Fibromyalgia |
| 93741547 | 9374154 | 23 | Deep vein thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93741547 | 9374154 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93741547 | 9374154 | Anxiety | |
| 93741547 | 9374154 | Aortic valve incompetence | |
| 93741547 | 9374154 | Arthritis | |
| 93741547 | 9374154 | Bipolar II disorder | |
| 93741547 | 9374154 | Emotional disorder | |
| 93741547 | 9374154 | Essential hypertension | |
| 93741547 | 9374154 | Gastrooesophageal reflux disease | |
| 93741547 | 9374154 | Generalised anxiety disorder | |
| 93741547 | 9374154 | Intervertebral disc degeneration | |
| 93741547 | 9374154 | Localised oedema | |
| 93741547 | 9374154 | Nausea | |
| 93741547 | 9374154 | Obsessive-compulsive disorder | |
| 93741547 | 9374154 | Oesophagitis | |
| 93741547 | 9374154 | Rheumatoid arthritis | |
| 93741547 | 9374154 | Skin ulcer | |
| 93741547 | 9374154 | Varicose vein | |
| 93741547 | 9374154 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |